Literature DB >> 6158559

Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.

S N Young, S Gauthier, G M Anderson, W C Purdy.   

Abstract

Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid were measured in cerebrospinal fluid, taken during pneumoencephalography, from a large series of patients, the majority of whom were epileptics, most of them receiving anticonvulsants. CSF indoleacetic acid reflects CNS tyrptamine metabolism in the same way that CSF 5-hydroxyindoleacetic acid reflects CNS 5-hydroxytryptamine metabolism. Our data suggest that (i) the brain tryptophan content is an important factor in the control of both 5-hydroxytryptamine and tryptamine synthesis (ii) brain 5-hydroxytryptamine metabolism exhibits a U-shaped relationship with age (iii) the mean brain tryptophan content and rate of 5-hydroxytryptamine metabolism are greater for women than men (iv) indoleamine metabolism is unaffected in untreated epileptics compared with non-epileptics, but anticonvulsant drugs decrease the rate of 5-hydrosytryptamine metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158559      PMCID: PMC490572          DOI: 10.1136/jnnp.43.5.438

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission.

Authors:  L L Simpson
Journal:  Neuropharmacology       Date:  1971-11       Impact factor: 5.250

Review 2.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

Authors:  E Garelis; S N Young; S Lal; T L Sourkes
Journal:  Brain Res       Date:  1974-10-11       Impact factor: 3.252

3.  5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration.

Authors:  G W Ashcroft; T B Crawford; R L Cundall; D L Davidson; J Dobson; R C Dow; D Eccleston; R W Loose; I A Pullar
Journal:  Psychol Med       Date:  1973-08       Impact factor: 7.723

4.  Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.

Authors:  V Sonninen; P Riekkinen; U K Rinne
Journal:  Neurology       Date:  1973-07       Impact factor: 9.910

5.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline.

Authors:  M Asberg; L Bertilsson; D Tuck; B Cronholm; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

6.  Active transport of 5-hydroxyindoleacetic acid by the rabbit choroid plexus in vitro. Blockade by probenecid and metabolic inhibitors.

Authors:  J Forn
Journal:  Biochem Pharmacol       Date:  1972-03-01       Impact factor: 5.858

7.  Relationship of monoamine metabolites in human cerebrospinal fluid to age.

Authors:  M B Bowers; F A Gerbode
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

8.  Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

Authors:  D Eccleston; G W Ashcroft; T B Crawford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

9.  Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.

Authors:  G W Ashcroft; I M Blackburn; D Eccleston; A I Glen; W Hartley; N E Kinloch; M Lonergan; L G Murray; I A Pullar
Journal:  Psychol Med       Date:  1973-08       Impact factor: 7.723

10.  Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.

Authors:  B A Shaywitz; D J Cohen; M B Bowers
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

View more
  20 in total

1.  Sex-related differences: do they matter?

Authors:  P Hrdina
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and alpha-[11C]methyl-L-tryptophan.

Authors:  H Okazawa; M Leyton; C Benkelfat; S Mzengeza; M Diksic
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 3.  Perils and pitfalls of reporting sex differences.

Authors:  Donna L Maney
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

4.  Differences between males and females in rates of serotonin synthesis in human brain.

Authors:  S Nishizawa; C Benkelfat; S N Young; M Leyton; S Mzengeza; C de Montigny; P Blier; M Diksic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Maternal neglect and the serotonin system are associated with daytime sleep in infant rhesus monkeys.

Authors:  Alexander Baxter; Elizabeth K Wood; Christina S Barr; Daniel B Kay; Stephen J Suomi; J Dee Higley
Journal:  Dev Psychopathol       Date:  2020-02

Review 6.  Adverse neuropsychiatric effects of anticonvulsant drugs.

Authors:  E H Reynolds; M R Trimble
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

7.  Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.

Authors:  J A Pratt; P Jenner; A L Johnson; S D Shorvon; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

8.  Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid.

Authors:  S N Young; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

9.  Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.

Authors:  S N Young; M H Joseph; S Gauthier
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

10.  Thiamine deficiency and cerebrospinal fluid 5-hydroxyindoleacetic acid: a preliminary study.

Authors:  M I Botez; S N Young; J Bachevalier; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.